Hussain et al showed that there was a synergistic effect between Eug and gemcitabine (an anticancer drug), which could improve the therapeutic index of cancer, and Eug could significantly reduced the expression of Bcl2, COX-2 and IL-1β [12]. Here, BCL2 is linked to cancer.